📰 Rna News
Page 39 - Rna News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rna. Real-time updates on events, politics, business and more.
February 28, 2023
Experts from the University of Barcelona, the Institute for Advanced Chemistry of Catalonia, the Institute of Microelectronics of Barcelona and the Aragon Nanoscience and Materials Institute of Aragon —a joint institute of the CSIC and the University of Zaragoza— have developed a new method to detect RNA viruses based on the triplex-forming probe technology.
February 28, 2023
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "Plasmid DNA Manufacturing Market, By Product Type, By Grade, By Application, By Manufacturing Type, By...
February 23, 2023
Moderna is partnering with Life Edit, a subsidiary of ElevateBio that offers a suite of gene-editing technologies. The deal brings together the capabilities of both companies, which aim to develop in vivo gene-editing therapies.Mod
February 23, 2023
Moderna Inc said on Wednesday its experimental mRNA skin cancer vaccine in combination with Merck & Co Inc blockbuster drug Keytruda has received breakthrough therapy designation from the U.S.... | February 22, 2023
February 23, 2023
A new University of California, Irvine-led study uncovers how a protein, APOBEC3B, could protect cells against many different types of RNA viruses like respiratory syncytial virus (RSV), SARS-CoV2, influenza virus, poliovirus and measles, helping to prevent disease.
February 22, 2023
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trialCAMBRIDGE, MA and RAHWAY, NJ / ACCESSWIRE / February 22, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering
February 18, 2023
HB 154, if passed, would amend Idaho state code, by adding a new section to penalize anyone from administering an mRNA vaccine in the state, with a misdemeanor.
February 16, 2023
MRNA-1010 demonstrated superiority on seroconversion rates for A/H3N2 and A/H1N1, superiority on geometric mean titer ratios for A/H3N2, and non-inferiority on geometric mean titer ratios for A/H1N1Non-inferiority
February 13, 2023
Researchers from Tokyo Metropolitan University and RIKEN CSRS have developed a new analytical platform based on liquid chromatography, mass spectrometry and software analysis that quantifies the structure of messenger RNA (mRNA) based medicines.
February 11, 2023
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech (BNTX) have started a Phase 1/2 trial for their mRNA vaccine candidates against shingles, an infectious disease caused by the reactivation